Authors:
Bruchfeld, A
Stahle, L
Andersson, J
Schvarcz, R
Citation: A. Bruchfeld et al., Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection - a pilot study, J VIRAL HEP, 8(4), 2001, pp. 287-292
Authors:
Carlsson, T
Lindahl, K
Schvarcz, R
Wejstal, R
Uhnoo, I
Shev, S
Reichard, O
Citation: T. Carlsson et al., HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin, J VIRAL HEP, 7(6), 2000, pp. 409-413
Authors:
Svensson, JO
Bruchfeld, A
Schvarcz, R
Stahle, L
Citation: Jo. Svensson et al., Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography, THER DRUG M, 22(2), 2000, pp. 215-218
Authors:
Schvarcz, R
Rudbeck, G
Soderdahl, G
Stahle, L
Citation: R. Schvarcz et al., Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV), TRANSPLANT, 69(10), 2000, pp. 2194-2195
Authors:
Schvarcz, R
Glaumann, H
Reichard, O
Weiland, O
Citation: R. Schvarcz et al., Histological and virological long-term outcome in patients treated with interferon-alpha 2b and ribavirin for chronic hepatitis C, J VIRAL HEP, 6(3), 1999, pp. 237-242
Citation: R. Schvarcz et al., Combination treatment for hepatitis C can be hazardous in patients co-infected with HIV, ANTIVIR TH, 3(4), 1998, pp. 233-234